Evidence map›Paper›PMID 30867568›Full record

ArticleOncogene2019

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors.

Sayka Barry, Eivind Carlsen, Pedro Marques, Craig E Stiles, Emanuela Gadaleta, Dan M Berney, Federico Roncaroli, Claude Chelala, Antonia Solomou, Maria Herincs and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Surgical anatomic findings of sphenoid sinus in 1009 Iranian patients with pituitary adenoma undergoing endoscopic transsphenoidal surgery.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  19. Tumour microenvironment and pituitary tumour behaviour.Journal of endocrinological investigation · 2023
    Review
  20. Pituitary Tumorigenesis-Implications for Management.Medicina (Kaunas, Lithuania) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Sayka BarryCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Eivind CarlsenDepartment of Pathology, STHF, N-3710, Skien, Norway.
Pedro MarquesCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Craig E StilesCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Emanuela GadaletaMolecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Dan M BerneyMolecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Federico RoncaroliDivision of Neuroscience & Experimental Psychology, University of Manchester, Manchester, M13 9PL, UK.
Claude ChelalaMolecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Antonia SolomouCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Maria HerincsCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Francisca CaimariCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Ashley B GrossmanCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Tatjana Crnogorac-JurcevicMolecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Oliver HaworthCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Carles Gaston-MassuetCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
Márta KorbonitsCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK. m.korbonits@qmul.ac.uk.ORCID http://orcid.org/0000-0002-4101-9432
Queen Mary University of London · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/M018539/1Wellcome TrustWellcome Trust 097970/Z/11/Z
6 · The paper itself

Abstract

The molecular mechanisms leading to aryl hydrocarbon receptor interacting protein (AIP) mutation-induced aggressive, young-onset growth hormone-secreting pituitary tumors are not fully understood. In this study, we have identified that AIP-mutation-positive tumors are infiltrated by a large number of macrophages compared to sporadic tumors. Tissue from pituitary-specific Aip-knockout (Aip

Indexed as

MutationNeoplasm InvasivenessTumor MicroenvironmentAnimalsBiomarkers, TumorChemokine CCL5Epithelial-Mesenchymal TransitionHumansIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutPituitary NeoplasmsReceptors, CCR5aryl hydrocarbon receptor-interacting proteinBiomarkers, TumorCCL5 protein, humanCCR5 protein, humanChemokine CCL5Intracellular Signaling Peptides and ProteinsReceptors, CCR5

Identifiers

PMID30867568
PMCPMC6755983
OpenAlexW2922321385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.